Search Results - "Huang, Pauline Y"

Protein profiles distinguish stable and progressive chronic lymphocytic leukemia by Huang, Pauline Y., Mactier, Swetlana, Armacki, Natalie, Giles Best, O., Belov, Larissa, Kaufman, Kimberley L., Pascovici, Dana, Mulligan, Stephen P., Christopherson, Richard I.

“…Patients with a stable chronic lymphocytic leukemia (CLL) double their blood lymphocyte count in >5 years, but may develop progressive disease with lymphocytes…”
Get full text

Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia by Huang, Pauline Y., Best, Oliver G., Almazi, Juhura G., Belov, Larissa, Davis, Zadie A., Majid, Aneela, Dyer, Martin J., Pascovici, Dana, Mulligan, Stephen P., Christopherson, Richard I.

“…Abstract Chronic lymphocytic leukemia (CLL) is clinically heterogeneous. While some patients have indolent disease for many years, 20-30% will progress and…”
Get full text

Surface profiles for subclassification of chronic lymphocytic leukemia by Huang, Pauline Y., Best, O. Giles, Belov, Larissa, Mulligan, Stephen P., Christopherson, Richard I.

“…Chronic lymphocytic leukemia (CLL) has a variable clinical course. Some patients have stable disease while others progress and require treatment. Levels of…”
Get full text

Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing by Zhou, Jerry, Belov, Larissa, Huang, Pauline Y., Shin, Joo-Shik, Solomon, Michael J., Chapuis, Pierre H., Bokey, Leslie, Chan, Charles, Clarke, Candice, Clarke, Stephen J., Christopherson, Richard I.

“…A procedure is described for the disaggregation of colorectal cancers (CRC) and normal intestinal mucosal tissues to produce suspensions of viable single…”
Get full text

Profiles of surface mosaics on chronic lymphocytic leukemias distinguish stable and progressive subtypes by Huang, Pauline Y, Kohnke, Philippa, Belov, Larissa, Best, O Giles, Mulligan, Stephen Peter, Christopherson, Richard I

“…Chronic lymphocytic leukemia (CLL) is a heterogeneous disease, some patients may survive for many years, while 20-30% of patients progress and may die within…”
Get full text

4.7 Identification of Novel Protein Markers of Progressive Chronic Lymphocytic Leukaemia by Huang, Pauline Y, Best, O. Giles, Mactier, S, Majid, Aneela, Dyer, Martin, Mulligan, Stephen P, Christopherson, Richard I

Get full text